Dow Pharma & Food Solutions Also Makes A Wide Range Of Excipients For More Effective Drug Delivery Systems. (Photo: Business Wire)

The Dow Chemical Company (NYSE:DOW) today announced that Marc van Gerwen has been named Global Business Director for Dow Pharma & Food Solutions. This business has been formerly known as Dow Wolff Cellulosics.
Marc van Gerwen, Global Business Director, Dow Pharma & Food Solutions (Photo: Business Wire)

Marc van Gerwen, Global Business Director, Dow Pharma & Food Solutions (Photo: Business Wire)

Dow Pharma & Food Solutions uses natural, plant-based cellulosic technology and companion chemistries to serve the needs of the fast-growing healthcare and medical markets, and to help make everyday foods a little tastier and healthier for consumers. This business also continues to cherish its foundational industrial applications, such as auto-honeycomb and anti-static films as well as conductive pastes for photovoltaic applications.

“This is a business built around helping solve some of the world’s most challenging problems,” said van Gerwen, who is based in Horgen, Switzerland, and assumed the leadership role in late February. “We help bring food to the table that tastes great, but perhaps has a little less fat in it, or gives the consumer that satisfied feeling with smaller amounts of food. We also make high-quality pharmaceutical ingredients designed to help get healing medications to the right part of the body at the right time in the right dosage.

“Our customers count on us to continually develop customized solutions to meet their needs and keep them competitive,” continued van Gerwen. “Understanding customer needs has been at the heart of our business for more than 40 years. We will continue to partner with them to help design even more impactful solutions, such as our new AFFINISOL TM solubilization excipients.”

“Marc is the right person for the job,” said Neil Carr, Business President for Functional Materials. “After two years as Marketing and Commercial Director, he knows the business, and many of its customers. He has a demonstrated talent for working closely with them to get good results for all.” Dow Pharma & Food Solutions is one of four business units within Dow’s Functional Materials business group.

If you liked this article you might like

Why Bayer's $66 Billion Takeover of Monsanto Probably Won't Happen Until 2018

Cramer: The Market Is Back to the Late '80s, Early '90s

DowDupont Closes Higher in First Day of Trading, Company Still Faces Challenges

FMC Stock's Impressive Rally Has Another 20% to Gain: Jim Cramer

Jim Cramer on Why FMC Was Upgraded by Bank of America